| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 153.51B | 149.54B | 138.22B | 130.18B | 123.48B | 118.01B |
| Gross Profit | 36.31B | 35.44B | 33.64B | 31.92B | 30.98B | 29.38B |
| EBITDA | 13.60B | 13.30B | 12.76B | 11.86B | 12.21B | 10.94B |
| Net Income | 4.36B | 4.73B | 5.81B | 6.11B | 5.81B | 5.48B |
Balance Sheet | ||||||
| Total Assets | 114.05B | 113.95B | 114.93B | 110.78B | 105.90B | 102.18B |
| Cash, Cash Equivalents and Short-Term Investments | 25.22B | 26.89B | 31.69B | 37.01B | 36.16B | 35.37B |
| Total Debt | 2.05B | 2.65B | 2.35B | 2.87B | 3.40B | 3.87B |
| Total Liabilities | 27.58B | 28.10B | 28.14B | 28.56B | 28.38B | 28.30B |
| Stockholders Equity | 85.79B | 85.19B | 86.18B | 81.66B | 77.00B | 73.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.99B | -372.00M | 2.94B | 6.49B | 6.54B |
| Operating Cash Flow | 0.00 | 10.10B | 8.04B | 8.59B | 10.13B | 9.23B |
| Investing Cash Flow | 0.00 | -11.41B | -10.21B | -6.24B | -6.74B | -4.20B |
| Financing Cash Flow | 0.00 | -5.20B | -3.20B | -2.43B | -2.90B | -1.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥127.66B | 9.20 | ― | 2.85% | 8.02% | 4.39% | |
72 Outperform | ¥1.04T | 10.73 | ― | 3.37% | 5.24% | 69.92% | |
71 Outperform | ¥89.47B | 9.76 | ― | 2.51% | 8.92% | -21.75% | |
64 Neutral | ¥402.44B | 11.14 | ― | 3.62% | -0.03% | -42.34% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥43.58B | 6.79 | ― | 3.90% | 0.17% | 58.30% |